0001104659-20-010896.txt : 20200204
0001104659-20-010896.hdr.sgml : 20200204
20200204205510
ACCESSION NUMBER: 0001104659-20-010896
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200131
FILED AS OF DATE: 20200204
DATE AS OF CHANGE: 20200204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crotty Robert
CENTRAL INDEX KEY: 0001600253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 20576084
MAIL ADDRESS:
STREET 1: 1301 2ND AVE
CITY: SEATTLE
STATE: WA
ZIP: 98101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
a4.xml
4
X0306
4
2020-01-31
0
0001641640
Nabriva Therapeutics plc
NBRV
0001600253
Crotty Robert
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
Gen Counsel & Corp Secretary
Ordinary Shares
86989
D
Ordinary Shares
2020-01-31
4
F
0
3892
1.35
D
83097
D
The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 63,750 previously reported restricted stock units and 23,239 ordinary shares.
/s/ Robert Crotty
2020-02-04